From Masterweb@mail.kc.net Fri Jul 17 15:46:01 1998
Return-Path: <Masterweb@mail.kc.net>
Delivered-To: bguenter@hal.qcc.sk.ca
Received: (qmail 17755 invoked by alias); 17 Jul 1998 15:46:00 -0000
Received: (qmail 17744 invoked from network); 17 Jul 1998 15:45:59 -0000
Received: from linus.vsource.com (qmailr@198.169.201.2)
  by hal.qcc.sk.ca with SMTP; 17 Jul 1998 15:45:59 -0000
Received: (qmail 4840 invoked by uid 559); 17 Jul 1998 15:29:42 -0000
Delivered-To: bguenter@gemprint.com
Received: (qmail 4834 invoked from network); 17 Jul 1998 15:29:41 -0000
Received: from mail.maranatha.net (207.51.124.5)
  by www.gemprint.com with SMTP; 17 Jul 1998 15:29:41 -0000
Received: by mail.maranatha.net from localhost
    (router,SLMail V2.6); Fri, 17 Jul 1998 08:16:27 -0400
Received: by mail.maranatha.net from 207.51.124.5
    (153.34.240.145::mail daemon; unverified,SLMail V2.6); Fri, 17 Jul 1998 08:16:23 -0400
Date: Fri, 17 Jul 98 07:58:27 EST
From: Masterweb@mail.kc.net
To: Masterweb@mail.kc.net
Subject: Cancer Treatment BREAKTHROUGH!!!!
Message-ID: <<199807160000.UAA01620@sdanet.org>>
Reply-To: Masterweb@mail.kc.net

DRAMATICALLY EFFECTIVE CANCER

TREATMENT IN FINAL DEVELOPMENT


Now you can participate in the multi-billion
dollar cancer treatment industry by owning
stock in this company before the "Wall Street
Analysts" discover it. The company is in
the final stages of researching and
developing this new drug to help cure soft
tissue cancers of the liver, breast and lungs.

This company is led by a very distinguished
team of Cancer Research Specialists who have
studied this disease for the last two decades.
The company holds the worldwide manufacturing
and marketing rights (except for the former
Soviet Union) for this drug.

The company is called :

NuOncology Labs Inc.

Trading Symbol: NLAB

Trades:   OTC  BB

Trials are now being conducted on over 200
human cancer patients with this new drug and
some very important announcements are
expected to come from NuOncology over the
next few weeks.

To have complete investor information sent to
you please call:

604.720.4153

